KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to -$137.0 million.

  • Biogen's Cash from Financing Activities fell 183417.72% to -$137.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$301.9 million, marking a year-over-year increase of 5583.03%. This contributed to the annual value of -$301.9 million for FY2025, which is 5583.03% up from last year.
  • Biogen's Cash from Financing Activities amounted to -$137.0 million in Q4 2025, which was down 183417.72% from -$130.2 million recorded in Q3 2025.
  • In the past 5 years, Biogen's Cash from Financing Activities ranged from a high of $848.6 million in Q3 2023 and a low of -$1.3 billion during Q3 2022
  • Over the past 5 years, Biogen's median Cash from Financing Activities value was -$86.8 million (recorded in 2023), while the average stood at -$233.5 million.
  • The largest annual percentage gain for Biogen's Cash from Financing Activities in the last 5 years was 16778.5% (2023), contrasted with its biggest fall of 863108.11% (2023).
  • Over the past 5 years, Biogen's Cash from Financing Activities (Quarter) stood at $9.8 million in 2021, then tumbled by 175.51% to -$7.4 million in 2022, then plummeted by 8631.08% to -$646.1 million in 2023, then soared by 101.22% to $7.9 million in 2024, then tumbled by 1834.18% to -$137.0 million in 2025.
  • Its Cash from Financing Activities stands at -$137.0 million for Q4 2025, versus -$130.2 million for Q3 2025 and -$11.7 million for Q2 2025.